Author’s Reply to Parvathaneni et al. Comment on: “Methotrexate Cutaneous Ulceration: A Systematic Review of Cases”

被引：0
|
作者：
Ronald Berna
Meghan Quinlan
Emily Baumrin
机构：
[1] University of Pennsylvania,Department of Dermatology, Perelman School of Medicine
[2] Pennsylvania College of Osteopathic Medicine,undefined
来源：
American Journal of Clinical Dermatology | 2023年 / 24卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：491 / 492
页数：1
相关论文
共 50 条
  • [21] Reply to the comment by Skrobik et al.
    Sophia de Rooij
    Evert de Jonge
    Intensive Care Medicine, 2004, 30 : 1500 - 1500
  • [22] Reply to the comment of Bertocchi et al.
    Alberto Baccini
    Giuseppe De Nicolao
    Scientometrics, 2016, 108 (3) : 1675 - 1684
  • [23] Reply to Comment by Vincent et al.
    Cowgill, Eric
    Niemi, Nathan A.
    Forte, Adam M.
    Trexler, Charles C.
    TECTONICS, 2018, 37 (03) : 1017 - 1028
  • [24] Reply to the comment by Osuka et al.
    Endo, Akira
    Shiraishi, Atsushi
    Fushimi, Kiyohide
    Otomo, Yasuhiro
    JOURNAL OF INTENSIVE CARE, 2020, 8 (01)
  • [25] Reply to comment of Legates et al.
    Labat, D
    Godderis, Y
    Probst, JL
    Guyot, JL
    ADVANCES IN WATER RESOURCES, 2005, 28 (12) : 1316 - 1319
  • [26] Reply to comment by Bednarsek et al.
    Peck, Victoria L.
    Tarling, Geraint A.
    Manno, Clara
    Harper, Elizabeth M.
    Deep-Sea Research Part II: Topical Studies in Oceanography, 2016, 127 : 57 - 59
  • [27] Reply to comment by Wallington et al.
    Ljungstrom, E
    Hallquist, M
    INTERNATIONAL JOURNAL OF CHEMICAL KINETICS, 1998, 30 (04) : 311 - 311
  • [28] Reply to the comment by Alarcon et al.
    Kapsala, N.
    Fanouriakis, A.
    Boumpas, D. T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (11) : 2342 - 2342
  • [29] Reply to the comment by Bellomo et al.
    Elizabeth Maccariello
    Márcio Soares
    Eduardo Rocha
    Intensive Care Medicine, 2007, 33 : 1851 - 1852
  • [30] Author’s Reply to Borg et al. Comment on: “EU’s New Pharmacovigilance Legislation: Considerations for Biosimilars”
    Begoña Calvo
    Drug Safety, 2014, 37 : 125 - 126
12345